Boehringer Ingelheim logo

Postdoctoral Regulatory Affairs Fellow - Policy and Intelligence

Boehringer Ingelheim

Ridgefield, CTOnsitePosted 1 day ago
InternshipInternRegulatory AffairsPharmaceutical
Original posting ↗

Summary

The Regulatory Policy and Intelligence Fellowship is designed to provide pharmacists with exposure to regulatory intelligence and policy activity within the pharmaceutical industry. The position will also offer the opportunity to complete rotations in areas within and beyond Regulatory Affairs.

Job description

The Fellow will be exposed to projects involving both US marketed products and investigational projects. Under supervision, the Fellow will:

  • Develop, compile, and integrate regulatory intelligence from health authorities, professional groups, publicly available information and BI.
  • Appropriately communicate regulatory intelligence within the organization.
  • Provide analysis, advice, and guidance on US/Global regulatory strategies to promote expedited product development and approval.
  • Research information on regulatory policies and departmental policies within and external to RA.
  • Research and implement processes to improve regulatory intelligence and collaboration.
  • Develop expertise on projects from the regulatory intelligence and policy perspective.
  • Collaborate with BI Government Affairs to ensure knowledge sharing of overlapping intelligence topics.

Duties & Responsibilities

Regulatory Expertise: The Fellow will develop basic regulatory policy and intelligence knowledge across the spectrum of BI assets and marketed products. Interact effectively within Regulatory Affairs and across functions, as a US regulatory advocate to achieve common goals for assigned projects, with supervision.

With supervision, the Regulatory Policy and Intelligence Fellow will:

  • Proactively review and evaluate relevant US regulations and guidelines, as well as evolving regulatory trends and developments for their impact on drug and device development activities and on existing development strategies
  • Lead requests for global country-level regulatory information from various partners
  • Handle the development of custom reports to support regulatory compliance and advise strategy
  • Collaborate with partners to support any compliance and process initiatives
  • Own the review and refinement of regulatory FDA guidance and recommendations by developing written comments reflecting BI’s priorities for submission to health authorities
  • Supervise the evaluation of new regulatory intelligence data sources and service providers
  • Serve as Regulatory intelligence lead on highly sophisticated cross-functional teams
  • Provide regular communications and briefings to global and regional policy management on relevant global regulatory policy issues
  • Participate in internal product team meetings to provide regulatory policy context for business decisions
  • Provide strategic regulatory advice to RA colleagues on drug development and device projects, registration, and marketed products in preparation for HA meetings
  • Develop training materials and participate as a facility member on new and emerging regulatory requirements for RA colleagues and other line functions
  • Analyze impact of important emerging regulatory policies and new requirements on projects and business
  • Prepare and coordinate internal customer feedback on proposed laws, regulations and guidances, to ensure consideration of BI’s positions by trade organizations
  • When appropriate, collaborate with Government Affairs to shape emerging legislative proposals
  • Develop targeted and appropriate automation of regulatory information

Position Expertise

Basic knowledge of pharmacy gained through Doctor of Pharmacy program. Fellow should have basic understanding of:

  • Food, Drug and Cosmetic Act
  • 21 CFR regulations relevant to drug/biologic development and registration
  • Other relevant US laws, regulations and guidance documents
  • Medical, pharmaceutical and scientific knowledge and understanding in the assigned therapeutic area

Requirements

  • Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy earned prior to the start date
  • Ability to perform MEDLINE and EMBASE literature searches
  • Strong intrapersonal, active listening, and problem-solving skills with an ability to work well in a team environment
  • Highly motivated and shows initiative in contributing to team deliverables
  • Receptive to receiving and quickly implementing constructive feedback
  • Ability to work independently within provided guidance from team leads
  • Adaptable and able to contribute to multiple Therapeutic Areas as needed
  • Excellent verbal and written communication skills
  • Proven experience working in a dynamic, high volume environment handling multiple tasks
  • Strong computer skills, including Outlook, Word, PowerPoint, and Excel
  • Foundational understanding of corporate structure, regulatory considerations and the drug development process in pharmacy
  • Must be legally authorized to work in the United States without restriction
  • Must be willing to take a drug test and post-offer physical (if required)
  • Must be 18 years of age or older

Company overview

Boehringer Ingelheim is a leading global research-driven biopharmaceutical company founded in 1885 and headquartered in Ingelheim am Rhein, Germany. As one of the world's top 20 pharmaceutical companies and the largest privately-owned pharmaceutical firm, it operates across three main business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. The company focuses on developing innovative therapies for diseases with high unmet medical needs, including cardiometabolic diseases, oncology, respiratory diseases, immunology, central nervous system disorders, and retinal health. With over 54,500 employees across 78 countries, Boehringer Ingelheim generated approximately €26.8 billion in revenue in 2024. The company maintains a strong research and development network with facilities in Germany, the United States, Austria, Japan, and Switzerland, investing significantly in advancing treatments for both human and animal health. Notable products include Jardiance (empagliflozin) for diabetes, Ofev (nintedanib) for pulmonary fibrosis, Spiriva (tiotropium) for respiratory conditions, and Pradaxa (dabigatran) for anticoagulation therapy.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.